alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>
 
                                                                    Exhibit 12.2
                                                                                

                      SECURITY CAPITAL GROUP INCORPORATED
              COMPUTATION OF RATIO OF EARNINGS TO COMBINED FIXED
                     CHARGES AND PREFERRED SHARE DIVIDENDS
                                        
                         (DOLLAR AMOUNTS IN THOUSANDS)

<TABLE>
<CAPTION>


                                                         Year Ended December 31,
                                         ---------------------------------------------------------
                                             1998        1997      1996       1995(a)     1994
                                         ---------   ---------   ---------   ---------   ---------
<S>                                      <C>         <C>         <C>         <C>         <C>

Net Earnings (loss) from Operations      $  67,480   $  38,241   $  (9,693)  $ (21,274)  $  11,849
Add:
    Interest Expense                        82,203     104,434     117,224     103,804      53,789
                                         ---------   ---------   ---------   ---------   ---------

Earnings as Adjusted                     $ 149,683   $ 142,675   $ 107,531   $  82,530   $  65,638
                                         =========   =========   =========   ==========  =========

Combined Fixed Charges and
    Preferred Share Dividends:
    Interest Expense                     $  82,203   $ 104,434   $ 117,224   $ 103,804   $  53,789
    Capitalized Interest                    26,703      69,883      11,448       4,404       3,184
                                         ---------   ---------   ---------   ---------   ---------

                                           108,906     174,317     128,672     108,208      56,973
    Preferred Share Dividends (b) (c)       22,315(d)   15,416      12,352          --          --
                                         ---------   ---------   ---------   ---------   ---------

Combined Fixed Charges and
    Preferred Share Dividends            $ 131,221   $ 189,733   $ 141,024   $ 108,208   $  56,973
                                         =========   =========   =========   =========   =========

Ratio of Earnings to Combined Fixed
    Charges and Preferred Share
    Dividends                                  1.1         0.8         0.8         0.8         1.2
                                         =========   =========   =========   =========   =========

</TABLE>
(a)  Excludes a one-time non-cash expense item ($158.4 million) incurred in
     acquiring the Services Division from a related party.
(b)  The Preferred dividends have been increased to show a pretax basis.
(c)  Security Capital had no preferred dividends prior to 1996.
(d)  Excludes a one-time non-cash dividend of $19.8 million incurred in
     conjunction with the exchange of Series A Preferred Shares for Series B
     Preferred Shares.
BEFORE THE 

DEPARTMENT OF TRANSPORTATION 

WASHINGTON, D.C. 

Agreements Adopted by the Traffic 

Conferences of the International Air 

Transport Association 

OST-2011- 00g, 9 

APPLICATION FOR APPROVAL OF AGREEMENTS 

BY THE 

INTERNATIONAL AIR TRANSPORT ASSOCIATION 

lATA AGREEMENT APPROVED & IMMUNIZED 

DOCKETOST-^*^^- A/i^P, ACTiONDATE ^•^-^'^'^ i "^^ l\ 

This approval and grant of antitrust immunity is subject, where applicable, 

to conditions previously imposed. 

This action is effective after 7 days unless a petition is filed under 

14 CFR 385.30 or a review is undertaken on tfie Department's own motion, 

in view of the agreement's n*nc*ntT«versial nature and the availability of 

the abov^rocedure, the^-jj^y M^^Jn 14 CFR 303.42 is waived. 

15Febnjary2011 

Communications with respect to 

this document should be sent to 

Douglas E. Lavin 

Regional Vice President - North America 

International Air Transport Association 

1776 K.St.N.W. #12* Floor 

Washington DC 20006
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 06-7910

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

GEORGE WILSON, III,

Defendant - Appellant.

No. 06-8007

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

GEORGE WILSON, III,

Defendant - Appellant.

Appeals from the United States District Court for the Eastern

District of Virginia, at Alexandria. Albert V. Bryan, Jr., Senior

District Judge. (1:93-cr-00461-AVB; 1:97-cv-00696-AVB)

Submitted: February 15, 2007 Decided: February 26, 2007

Before NIEMEYER, KING, and DUNCAN, Circuit Judges.
- 2 -

Affirmed by unpublished per curiam opinion.

George Wilson, III, Appellant Pro Se. John Thomas Martin, OFFICE

OF THE UNITED STATES ATTORNEY, Alexandria, Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit.
*To the extent Wilson may be seeking authorization from this

court to file a second or successive 28 U.S.C. § 2255 (2000)

motion, we deny the request. 

- 3 -

PER CURIAM:

In these consolidated appeals, George Wilson III seeks to

appeal the district court’s order construing his motion as one

filed under 28 U.S.C. § 2255 (2000) and denying relief because he

did not have authorization from this court under 28 U.S.C. § 2244

(2000). He also appeals two margin orders denying his motions for

reconsideration. Wilson was clearly attacking his sentence and

because he had previously filed a § 2255 motion, the district court

correctly found it was without authority to consider these filings

unless Wilson had authorization from this court.* See § 2244. 

In addition, Wilson appeals the district court’s orders

denying his request for records and files and denying two motions

for reconsideration. Because there was no reason to grant the

relief sought, we affirm. 

Accordingly, we affirm the district court’s orders. We

dispense with oral argument because the facts and legal contentions

are adequately presented in the materials before the court and

argument would not aid the decisional process.

AFFIRMED
EXHIBIT 32


CERTIFICATION PURSUANT TO SECTION 906

Pursuant to 18 U.S.C. Section 1350 as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, I, the
undersigned officer of Sherwood Acquisition Corporation
(the "Company"), hereby certify to my knowledge that:

The Report on Form 10-Q for the quarter ended Septembr 30,
2011 of the Company fully complies, in all material respects,
with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, and the information contained in the
Report fairly represents, in all material respects, the
financial condition and results of operations of the Company.

A signed original of this written statement required by Section
906 has been provided to the Company and will be retained by
the Company and furnished to the Securities and Exchange
Commission or its staff upon request.


                             /s/ Peter Tong
		                  President

                             /s/ Yue-Zhong Yuan
                                  Treasurer


Date: November 15, 2011
#### Maria R. PERIUT, Appellant, v. Augusto PERIUT, Appellee.

No. 71-808.

District Court of Appeal of Florida, Third District.

Feb. 29, 1972.

Rehearing Denied March 22, 1972.

Robert J. Lewison, Miami, for appellant.

Blas M. Rocafort, III, Miami, for ap-pellee.

Before SWANN, C. J., and PEARSON and CHARLES CARROLL, JJ.

PER CURIAM.

Affirmed upon authority of the rule stated in Cooke v. Cooke, Fla.App.1961, 126 So.2d 160.
EXHIBIT 32

CERTIFICATION PURSUANT TO
18 U.S.C. {section} 1350,
AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Noble China Holdings Limited (the "Company") on Form 10-Q for the period ending September 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Jeremy Mork, Chief Executive and Financial  Officer of the Company, certify, pursuant to 18 U.S.C. {section} 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002, that, to the best of my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.



|Dated:  May 25, 2011
By  /s/ Jeremy Mork
-----------------------------
    Jeremy Mork
    Chief Executive and  Financial Officer
   (Principal Executive and Financial Officer)
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|
# C_2015175EN.01000501.xml

| 29.5.2015 | EN | Official Journal of the European Union | C 175/5 |
| --- | --- | --- | --- |

29.5.2015

EN

Official Journal of the European Union

C 175/5

---

Notice for the attention of persons and entities subject to the restrictive measures provided for in Council Decision 2013/255/CFSP and in Council Regulation (EU) No 36/2012 concerning restrictive measures in view of the situation in Syria

(2015/C 175/03)

The following information is brought to the attention of the persons and entities designated in Annex I to Council Decision 2013/255/CFSP, as amended by Council Decision (CFSP) 2015/837 (1), and in Annex II to Council Regulation (EU) No 36/2012, as implemented by Council Implementing Regulation (EU) 2015/828 (2), concerning restrictive measures in view of the situation in Syria.

1

2

The Council of the European Union, after having reviewed the list of persons and entities designated in the above-mentioned Annexes, has determined that the restrictive measures provided for in Decision 2013/255/CFSP and in Regulation (EU) No 36/2012 should continue to apply to those persons and entities.

The attention of the persons and entities concerned is drawn to the possibility of making an application to the competent authorities of the relevant Member State(s) as indicated on the websites in Annex IIa to Regulation (EU) No 36/2012, in order to obtain an authorisation to use frozen funds for basic needs or specific payments (cf. Article 16 of the Regulation).

The persons and entities concerned may submit a request to the Council before 1 March 2016, together with supporting documentation that the decision to include them on the above-mentioned list should be reconsidered to the following address:

| Council of the European Union |
| --- |
| General Secretariat |
| DG C 1C |
| Rue de la Loi/Wetstraat 175 |
| 1048 Bruxelles/Brussel |
| BELGIQUE/BELGIË |
| E-mail: sanctions@consilium.europa.eu |

Council of the European Union

General Secretariat

DG C 1C

Rue de la Loi/Wetstraat 175

1048 Bruxelles/Brussel

BELGIQUE/BELGIË

E-mail: sanctions@consilium.europa.eu

Any observations received will be taken into account for the purpose of the Council’s next review, pursuant to Article 34 of Decision 2013/255/CFSP and Article 32(4) of Regulation (EU) No 36/2012, of the list of designated persons and entities.

---

(1)  OJ L 132, 29.5.2015, p. 82.

1

(2)  OJ L 132, 29.5.2015, p. 3.

2

---
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
AND

CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002



In connection with the quarterly Report of
Nano Mobile Healthcare, Inc. (the “Company”) on Form 10-Q for the quarter ended December 31, 2015 filed with the Securities
and Exchange Commission (the “Report”), I, Joseph C. Peters, Chief Executive Officer of the Company, certify, pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | 1. | The Report fully complies with the requirements of Section 13(a)
of the Securities Exchange Act of 1934; and
| | -- | ------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material
respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations
of the Company for the periods presented.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|By:    | /s/ Joseph C. Peters                                                 
|------ | ---------------------------------------------------------------------
|Name:  | Joseph C. Peters                                                     
|Title: | Principal Executive Officer, Principal Financial Officer and Director
|Date:  | February 22, 2016                                                    



This certification has been furnished solely pursuant to Section
906 of the Sarbanes-Oxley Act of 2002.





---
SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549

FORM 8-K

Current Report Pursuant to
Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report: October 5, 2000

TARGET RECEIVABLES CORPORATION(Exact name of registrant as specified in its charter)

Minnesota
(State or other jurisdiction of incorporation)

0-26930

41-1812153(Commission File Number)

(I.R.S. Employer Identification Number)


Target
Receivables Corporation
80 South Eighth Street
14th Floor, Suite 1401
Minneapolis, Minnesota 55402
(612)370-6530
(Address, including Zip Code, and Telephone Number,
Including Area Code, of Registrant's Principal Executive Office)



## 

Item 5:  Other Events

The Monthly Servicer's Certificates for the Monthly Period ended August 26, 2000 and the Monthly Certificateholders' Statements for the Monthly Period ended August 26, 2000, with respect
to the Class A Asset Backed Certificates, 6.25% Series 1997-1, the Class B Asset Backed Certificates, Series 1997-1, the Class A Asset Backed
Certificates, 5.90% Series 1998-1 and the Class B Asset Backed Certificates, Series 1998-1, issued by the Target Credit Card Master Trust, were delivered
to the Trustee on September 21, 2000, and the Monthly Certificateholders' Statements were then distributed to Certificateholders on September 25, 2000.

The
above described Monthly Servicer's Certificates are filed as Exhibits 20.1 and 20.3 to this Report. The above described Monthly Certificateholders' Statements are filed as
Exhibits 20.2 and 20.4 to this Report.

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|Dated: October 5, 2000 |  |                                |  |                             
|---------------------- |  | ------------------------------ |  | ----------------------------
|                       |  | TARGET RECEIVABLES CORPORATION
|                       |  | By:                            |  | /s/ Stephen C. Kowalke      
|                       |  | Name:                          |  | Stephen C. Kowalke          
|                       |  | Title:                         |  | Vice President and Treasurer



## 

EXHIBIT INDEX

Exhibit Number

Description20.1

Series 1997-1 Monthly Servicer's Certificate for the Monthly Period ended August 26, 2000.20.2

Series 1997-1 Monthly Certificateholders' Statement for the Monthly Period ended August 26, 2000.20.3

Series 1998-1 Monthly Servicer's Certificate for the Monthly Period ended August 26, 2000.20.4

Series 1998-1 Monthly Certificateholders' Statement for the Monthly Period ended August 26, 2000.




## QuickLinks
<PAGE>

                         CONSENT OF INDEPENDENT AUDITORS



To the Board of Directors and Stockholders
Isonics Corporation


We have issued our report dated June 26, 2000, accompanying the consolidated
financial statements of Isonics Corporation and Subsidiaries appearing in the
Company's Annual Report on Form 10-KSB for the year ended April 30, 2000, which
is incorporated by reference in this Registration Statement on Form S-3. We
hereby consent to the incorporation by reference in the Registration Statement
and Prospectus of the aforementioned report and to the use our name as it
appears under the caption "Experts."


/s/ GRANT THORNTON LLP


San Jose, California
September 25, 2000
103D CONGRESS

2D SESSION H. R. 3770

AN ACT

To designate the United States courthouse located

and Federal Building’’.house as the ‘‘Edward J. Schwartz Courthouseand the Federal building attached to the courtat 940 Front Street in San Diego, California,
103D CONGRESS

2D SESSION H. R. 3770

AN ACT

To designate the United States courthouse located at 940

Front Street in San Diego, California, and the Federal

building attached to the courthouse as the ‘‘Edward J.

Schwartz Courthouse and Federal Building’’.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. DESIGNATION.

4 The United States courthouse located at 940 Front

5 Street in San Diego, California, and the Federal building

6 attached to the courthouse shall be known and designated

7 as the ‘‘Edward J. Schwartz Courthouse and Federal

8 Building’’.
2

•HR 3770 EH

1 SEC. 2. REFERENCES.

2 Any reference in a law, map, regulation, document,

3 paper, or other record of the United States to the court4 house and Federal building referred to in section 1 shall

5 be deemed to be a reference to the ‘‘Edward J. Schwartz

6 Courthouse and Federal Building’’.

Passed the House of Representatives April 13, 1994.

Attest:

Clerk.
[Federal Register Volume 83, Number 168 (Wednesday, August 29, 2018)]
[Notices]
[Page 44058]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-18654]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Center for 
Scientific Review Advisory Council.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Center for Scientific Review Advisory 
Council.
    Date: September 24, 2018
    Time: 8:30 a.m. to 3:00 p.m.
    Agenda: Provide advice to the Director, Center for Scientific 
Review (CSR), on matters related to planning, execution, conduct, 
support, review, evaluation and receipt and referral of grant 
applications at CSR.
    Place: National Institutes of Health, Third Floor Conference 
Center, 6701 Rockledge Drive, Bethesda, MD 20892.
    Contact Person: Christine L Melchior, Ph.D., Senior Advisor to 
the Director, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3030, MSC 7776, Bethesda, MD 
20892, (301) 435-1111, <a href="/cdn-cgi/l/email-protection#cfa2aaa3aca7a6a0ac8facbcbde1a1a6a7e1a8a0b9"><span class="__cf_email__" data-cfemail="6c0109000f0405030f2c0f1f1e42020504420b031a">[email protected]</span></a>.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance into NIH buildings. Visitors will be asked 
to show one form of identification (for example, a government-issued 
photo ID, driver's license, or passport) and to state the purpose of 
their visit. Information is also available on the Institute's/
Center's home page: http://public.csr.nih.gov/aboutcsr/CSROrganization/Pages/CSRAC.aspx, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: August 22, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-18654 Filed 8-28-18; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
V

103D CONGRESS

2D SESSION H. R. 3891

To waive certain time limitations with respect to awarding the Medal of

Honor to Rudolph Salais Vela.

IN THE HOUSE OF REPRESENTATIVES

FEBRUARY 23, 1994

Mr. TEJEDA introduced the following bill; which was referred to the

Committee on Armed Services

A BILL

To waive certain time limitations with respect to awarding

the Medal of Honor to Rudolph Salais Vela.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 That, notwithstanding any time limitation contained in

4 section 3744(b) of title 10, United States Code, the Presi5 dent may award, and present in the name of the Congress,

6 the Medal of Honor to Rudolph Salais Vela of San Anto7 nio, Texas, for conspicuous acts of valor performed by him

8 while serving as a private first class in the United States

9 Army during combat operations on Okinawa during June

10 1945.
2

•HR 3891 IH

Æ
I

103D CONGRESS

1ST SESSION H. R. 3669

To amend the Public Health Service Act with respect to determining the

amount of a supplemental grant under the emergency relief program

regarding the human immunodeficiency virus.

IN THE HOUSE OF REPRESENTATIVES

NOVEMBER 22, 1993

Mr. NADLER introduced the following bill; which was referred to the

Committee on Energy and Commerce

A BILL

To amend the Public Health Service Act with respect to

determining the amount of a supplemental grant under

the emergency relief program regarding the human

immunodeficiency virus.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘HIV Emergency Sup5 plemental Grants Amendments of 1993’’.
2

•HR 3669 IH

1 SEC. 2. DETERMINATION OF AMOUNT OF SUPPLEMENTAL

2 GRANT UNDER EMERGENCY RELIEF PRO3 GRAM REGARDING HUMAN

4 IMMUNODEFICIENCY VIRUS.

5 (a) IN GENERAL.—Section 2603(b)(3) of the Public

6 Health Service Act (42 U.S.C. 300ff–13(b)(3)) is amend7 ed by inserting before the period the following: ‘‘, and such

8 amount shall be based primarily on the need of the eligible

9 area for such a grant as indicated by the information pro10 vided in the application under paragraph (1) of such sec11 tion’’.

12 (b) CONFORMING AMENDMENT REGARDING APPLI13 CATIONS FOR SUPPLEMENTAL GRANTS.—Section 2605(b)

14 of the Public Health Service Act (42 U.S.C. 300ff–15(b))

15 is amended—

16 (1) by redesignating paragraphs (1) through

17 (4) as paragraphs (2) through (5), respectively; and

18 (2) by inserting before paragraph (2) (as so re19 designated) the following paragraph:

20 ‘‘(1) the cumulative number of cases reported

21 and confirmed under section 2601(a)(1)s;’’.

22 SEC. 3. EFFECTIVE DATE.

23 This Act takes effect October 1, 1993, or upon the

24 date of the enactment of this Act, whichever occurs later.

Æ